Changes over time in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: Perspectives from the Worcester heart attack study

American Heart Journal

Volumn 139, Issue 6, 2000, Pages 1014-1021

  Thompson, Craig A ^a   Yarzebski, Jorge ^b   Goldberg, Robert J ^b   Lessard, Darleen ^b   Gore, Joel M ^b   Dalen, James E ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; FEMALE; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT MONITORING; POPULATION RISK; PRIORITY JOURNAL; SURVIVAL;

EID: 0034123557     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.106160     Document Type: Article

References (15)

1. Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation 1998;98:1802-20.
2. Antman EM. TIMI 11B: enoxaparin versus unfractionated heparin for unstable angina or non-Q-wave myocardial infarction: a double-blind, placebo-controlled, parallel-group, multicenter trial: rationale, study design, and methods: Thrombolysis in Myocardial Infarction (TIMI) 11B Trial Investigators. Am Heart J 1998;135:S353-60.
3. Braunwald E, Maseri A, Armstrong PW, et al. Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes. Eur Heart J 1998;19:022-30.
4. Chiriboga D, Yarzebski J, Goldberg RJ, et al. Temporal Trends (1975 through 1990) in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: a communitywide perspective. Circulation 1994;89:998-1003.
5. Goldberg R, Gore J, Alpert J, et al. Recent changes in attack and survival rates of acute myocardial infarction. JAMA 1986;255:2774-9.
6. Goldberg R, Gore J, Alpert J, et al. Incidence and case-fatality rates of acute myocardial infarction. Am Heart J 1988;115:761-7.
7. Goldberg RJ, Yarzebski J, Lessard D, et al. A 2-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999;33:1533-9.
8. Goldberg RJ, Samad NA, Yarzebski J, et al. Temporal trends (1975 to 1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction (Worcester Heart Attack Study). N Engl J Med 1999;340:1162-8.
9. Spencer FA, Meyer TE, Goldberg RJ, et al. Twenty-year trends (1975-1995) in the incidence, in-hospital, and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol 1999;34:1378-87.
10. Behar A, Goldbourt U, Reicher-Reiss H, et al. Prognosis of Acute myocardial infarction complicated by primary ventricular fibrillation: principal investigators of the SPRINT Study. Am J Cardiol 1990;66:1208-11.
11. Volpi A, Cavalli A, Santoro L, et al. Incidence and prognosis of early primary ventricular fibrillation in acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Soprawivenza nell'Infarto Miocardico (GISSI-2) database. Am J Cardiol 1998;82:265-71.
12. Nicod P, Gilpin E, Dittrich H, et al. Late clinical outcomes in patients with early ventricular fibrillation after acute myocardial infarction. J Am Coll Cardiol 1988;11:464-70.
13. Jensen G, Torp-Pedersen C, Kober L, et al. Prognosis of late versus early ventricular fibrillation in acute myocardial infarction. Am J Cardiol 1990;66:5-10.
14. Antman E, Berlin J. Declining incidence of ventricular fibrillation in myocardial infarction: implications for the prophylactic use of lidocaine. Circulation 1992;86:764-73.
15. Brezins M, Elyassov S, Elimelech I, et al. Comparison of patients with acute myocardial infarction with and without ventricular fibrillation. Am J Cardiol 1996;78:948-50.